Search

everythinglearnresearchcommunity

for

Search:↓

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The committee decided not to approve the drug due to low effectiveness and high risks.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Nanoparticle systems make cancer treatment less toxic.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Gefitinib can cause scalp skin issues and permanent hair loss.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.